Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
Conditions
Extrahepatic Cholangiocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aichi Medical University, Aichi, Japan
Nagoya City University Hospital, Aichi, Japan
Nagoya City University Midori Municipal Hospital, Aichi, Japan
Gifu University Hospital, Gifu, Japan
Pusan National University Hospital, Busan, South Korea
Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
Study leads
Tadahisa Inoue, Associate Professor
Principal Investigator
Department of Gastroenterology, Aichi Medical University
Jae Hee Cho, Professor
Principal Investigator
Department of Internal Medicine, Institute of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine